Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Autori principali: Shinya Takasaki (Autore), Hisanobu Adachi (Autore), Yoshihide Kawasaki (Autore), Masafumi Kikuchi (Autore), Akihiro Ito (Autore), Nariyasu Mano (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...